An observational study in Charcot Marie Tooth Disease (CMT), sponsored by Artvin Coruh University. Not yet recruiting at 1 site in Turkey (Türkiye). Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by Artvin Coruh University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 11 studies in Charcot-Marie-Tooth Disease with a site in Turkey — 1 open to participants now, 1 under way, none of them phase 3. Charcot-Marie-Tooth Disease · Turkey.
Among the 11 studies in Charcot-Marie-Tooth Disease with a site in Turkey, this one is the only one that started in 2027, is one of 2 observational ones, and was the 11th registered.
115 studies on the registry are indexed under Charcot-Marie-Tooth Disease; 39 are open to participants now.
Browse Charcot-Marie-Tooth Disease studies →1 of the 11 studies in Charcot-Marie-Tooth Disease with a site in Turkey is open now.
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 31 Charcot-Marie-Tooth Disease studies recruiting now, 14 (45%) set no upper age limit and 13 (42%) stop at 75 or younger; 14 take children under 18; 13 take healthy volunteers.
This study: all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
11 studies; the count open now beside each. This study's row is marked.
First in 2021; this study’s year is marked. 1 started in 2027.
This study's planned enrollment of 70 is below the median of 120 across 49 observational studies indexed under Charcot-Marie-Tooth Disease.
Median enrollment 60 across the 9 interventional studies, 73 across the 2 observational. Of the 9 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 11 have an industry lead sponsor. The 8 most frequent:
Artvin Coruh University is the lead sponsor of 31 studies on the registry; 18 are open to participants now.
Artvin Coruh University has 1 study filed under Charcot-Marie-Tooth Disease — fewer than ten, so there is no comparison to draw.
1 of the studies in Charcot-Marie-Tooth Disease with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07945054Artvin Coruh UniversityAn Evaluation of the Usefulness, Quality, and Reliability of YouTube®-Based Exercise Videos | 2027-01-15 |
Add it to your calendar (.ics) → With an account.
Among the 11 studies in Charcot-Marie-Tooth Disease with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Objective: Evaluate the reliability and quality of YouTube® information and exercise videos about Charcot-Marie-Tooth (CMT) disease.
Methods: In January 2027, an English-language YouTube search will use "Charcot-Marie-Tooth exercises." Videos will be categorized by content and upload source. Information reliability will be assessed with modified DISCERN (mDISCERN); quality will be rated using the Global Quality Scale (GQS) and JAMA criteria. Two neurological rehabilitation physical therapists will independently assess each video. A third evaluator will resolve disagreements and make the final decision.
Videos about CMT disease will be included in the study.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
YouTube exercise videos about Charcot-Marie-Tooth disease will be included in the study.
A modified 5-point DISCERN (mDISCERN)
Video reliability will be assessed with the modified DISCERN (mDISCERN), a valid and reliable tool for online health information (Cronbach's alpha = 0.777; ICC = 0.823, p \< 0.001). It retains the original framework and rates each item on a 5-point Likert scale, coded as 1 ("yes") or 0 ("no"). Higher scores indicate more reliable video-based health information.
Time frame: Single assessment at enrollment
Global Quality Scale (GQS)
Video quality will be assessed with a 5-point GQS: scores of 1-2 indicate low quality, 3 moderate quality, and 4-5 high quality. Higher scores indicate better quality. The GQS shows high inter- and intra-rater reliability: inter-rater agreement was high (Cohen's κ = 0.82; 95% CI: 0.78-0.86), and intra-rater ICCs were 0.87 (95% CI: 0.83-0.91) for the first rater and 0.89 (95% CI: 0.85-0.93) for the second.
Time frame: Single assessment at enrollment
Journal of the American Medical Association (JAMA)
Video quality will also be assessed using the 4-point JAMA scale, which evaluates authorship, citation, information, and timeliness. Higher scores indicate better quality.
Time frame: Single assessment at enrollment
Plan to share: No
Start is estimated for Jan 2027; primary completion for Jan 2027, 0 months later.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Artvin Coruh University